Although Tregs contained a higher percentage of effector/memory Tregs in BPH patients than in healthy controls (Figure 2A), CD39 expression on effector/memory Tregs was still lower in BPH patients (Figure 2A). This evidence concerns the gene ENTPD1 and benign prostatic hyperplasia.